Benzinga | Nov 12, 2020 04:16PM EST

Alpine Immune Sciences Q3 EPS $(0.28) Misses $(0.23) Estimate, Sales $1.91M Up From $289.00K YoY

Alpine Immune Sciences (NASDAQ:ALPN) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.23) by 21.74 percent. This is a 54.84 percent increase over losses of $(0.62) per share from the same period last year. The company reported $1.91 million in sales this quarter. This is a 561.94 percent increase over sales of $289.00 thousand the same period last year.